Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of buspirone and Ritalin in the treatment of ADHD
IRCT201011101556N17Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buspirone and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Apr 2010; status: completed.
02
Drugs
buspironemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201011101556N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201011101556N17.